352
views
0
recommends
+1 Recommend
0 collections
    8
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HDAC2 negatively regulates memory formation and synaptic plasticity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chromatin modifications, especially histone-tail acetylation, have been implicated in memory formation. Increased histone-tail acetylation induced by inhibitors of histone deacetylases (HDACis) facilitates learning and memory in wildtype mice as well as in mouse models of neurodegeneration. Harnessing the therapeutic potential of HDACi requires knowledge of the specific HDAC family member(s) linked to cognitive enhancement. Here we show that neuron-specific overexpression of HDAC2, but not HDAC1, reduced dendritic spine density, synapse number, synaptic plasticity, and memory formation. Conversely, HDAC2 deficiency resulted in increased synapse number and memory facilitation, similar to chronic HDACi treatment in mice. Notably, reduced synapse number and learning impairment of HDAC2-overexpressing mice were ameliorated by chronic HDACi treatment. Correspondingly, HDACi treatment failed to further facilitate memory formation in HDAC2-deficient mice. Furthermore, analysis of promoter occupancy revealed association of HDAC2 with the promoters of genes implicated in synaptic plasticity and memory formation. Together, our results suggest that HDAC2 plays a role in modulating synaptic plasticity and long-lasting changes of neural circuits, which in turn negatively regulates learning and memory. These observations encourage the development and testing of HDAC2-selective inhibitors for human diseases associated with memory impairment.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Synaptic plasticity and memory: an evaluation of the hypothesis.

          Changing the strength of connections between neurons is widely assumed to be the mechanism by which memory traces are encoded and stored in the central nervous system. In its most general form, the synaptic plasticity and memory hypothesis states that "activity-dependent synaptic plasticity is induced at appropriate synapses during memory formation and is both necessary and sufficient for the information storage underlying the type of memory mediated by the brain area in which that plasticity is observed." We outline a set of criteria by which this hypothesis can be judged and describe a range of experimental strategies used to investigate it. We review both classical and newly discovered properties of synaptic plasticity and stress the importance of the neural architecture and synaptic learning rules of the network in which it is embedded. The greater part of the article focuses on types of memory mediated by the hippocampus, amygdala, and cortex. We conclude that a wealth of data supports the notion that synaptic plasticity is necessary for learning and memory, but that little data currently supports the notion of sufficiency.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.

            To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Place navigation impaired in rats with hippocampal lesions.

                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                27 October 2012
                7 May 2009
                15 November 2012
                : 459
                : 7243
                : 55-60
                Affiliations
                [1 ]Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
                [2 ]Howard Hughes Medical Institute
                [3 ]Stanley Center for Psychiatric Research, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA
                [4 ]Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02142, USA
                [5 ]Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
                [6 ]Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
                [7 ]Center for Applied Cancer Science, Belfer Institute for Innovative Cancer Science, Departments of Medical Oncology, Medicine and Genetics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
                [9 ]Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA
                Author notes
                [* ]To whom correspondence should be addressed. lhtsai@ 123456mit.edu
                [#]

                these authors contributed equally to this work

                [8]

                Present address: Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands

                Article
                NIHMS409622
                10.1038/nature07925
                3498958
                19424149
                85aaaf37-18fb-4e2a-86e4-826a417acd98

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Award ID: R01 NS051874 || NS
                Funded by: National Institute on Drug Abuse : NIDA
                Award ID: R01 DA028301-02 || DA
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article